Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 23511609)

1.

Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression.

Winner J, Allen JD, Altar CA, Spahic-Mihajlovic A.

Transl Psychiatry. 2013 Mar 19;3:e242. doi: 10.1038/tp.2013.2.

2.

Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.

Altar CA, Carhart JM, Allen JD, Hall-Flavin DK, Dechairo BM, Winner JG.

Pharmacogenomics J. 2015 Feb 17. doi: 10.1038/tpj.2014.85. [Epub ahead of print]

PMID:
25686762
3.

The relationship of antidepressant prescribing concentration to treatment duration and cost.

Hodgkin D, Merrick EL, Hiatt D.

J Ment Health Policy Econ. 2012 Mar;15(1):3-11.

4.

Pharmacogenomics of antidepressant drugs.

Horstmann S, Binder EB.

Pharmacol Ther. 2009 Oct;124(1):57-73. doi: 10.1016/j.pharmthera.2009.06.007. Epub 2009 Jun 27. Review.

PMID:
19563827
5.

[Antidepressants consumption in the global population in France].

Olié JP, Elomari F, Spadone C, Lépine JP.

Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7. French.

PMID:
12386542
6.

Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.

Tournier M, Moride Y, Crott R, du Fort GG, Ducruet T.

J Affect Disord. 2009 May;115(1-2):160-6. doi: 10.1016/j.jad.2008.07.004. Epub 2008 Aug 9.

PMID:
18694602
7.

Using a pharmacogenomic algorithm to guide the treatment of depression.

Hall-Flavin DK, Winner JG, Allen JD, Jordan JJ, Nesheim RS, Snyder KA, Drews MS, Eisterhold LL, Biernacka JM, Mrazek DA.

Transl Psychiatry. 2012 Oct 16;2:e172. doi: 10.1038/tp.2012.99.

8.

Antidepressant adherence and medical resource use among managed care patients with anxiety disorders.

Stein MB, Cantrell CR, Sokol MC, Eaddy MT, Shah MB.

Psychiatr Serv. 2006 May;57(5):673-80.

PMID:
16675762
9.

A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database.

Coupland CA, Dhiman P, Barton G, Morriss R, Arthur A, Sach T, Hippisley-Cox J.

Health Technol Assess. 2011 Aug;15(28):1-202, iii-iv. doi: 10.3310/hta15280.

10.

Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy.

Altar CA, Hornberger J, Shewade A, Cruz V, Garrison J, Mrazek D.

Int Rev Psychiatry. 2013 Oct;25(5):509-33. doi: 10.3109/09540261.2013.825579. Review.

PMID:
24151799
11.

Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization.

McLaughlin TP, Khandker RK, Kruzikas DT, Tummala R.

J Clin Psychiatry. 2006 Aug;67(8):1187-93.

PMID:
16965195
12.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
13.

The costs associated with antidepressant use in depression and anxiety in community-living older adults.

Vasiliadis HM, Latimer E, Dionne PA, Préville M.

Can J Psychiatry. 2013 Apr;58(4):201-9.

PMID:
23547643
14.

Economic outcomes with antidepressant pharmacotherapy: a retrospective intent-to-treat analysis.

Sclar DA, Skaer TL, Robison LM, Galin RS, Legg RF, Nemec NL.

J Clin Psychiatry. 1998;59 Suppl 2:13-7.

PMID:
9559755
15.

The cost of comorbid depression and pain for individuals diagnosed with generalized anxiety disorder.

Zhu B, Zhao Z, Ye W, Marciniak MD, Swindle R.

J Nerv Ment Dis. 2009 Feb;197(2):136-9. doi: 10.1097/NMD.0b013e3181963486.

PMID:
19214050
16.

[Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].

Norton J, de Roquefeuil G, David M, Boulenger JP, Ritchie K, Mann A.

Encephale. 2009 Dec;35(6):560-9. doi: 10.1016/j.encep.2008.06.018. Epub . French.

PMID:
20004287
17.

Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder.

Lohoff FW, Narasimhan S, Rickels K.

Pharmacogenomics J. 2013 Oct;13(5):464-9. doi: 10.1038/tpj.2012.33. Epub 2012 Aug 21.

PMID:
22907732
18.

Health care utilization and its costs for depressed veterans with and without comorbid PTSD symptoms.

Chan D, Cheadle AD, Reiber G, Unützer J, Chaney EF.

Psychiatr Serv. 2009 Dec;60(12):1612-7. doi: 10.1176/appi.ps.60.12.1612.

PMID:
19952151
19.

Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization.

Sclar DA, Robison LM, Skaer TL, Legg RF, Nemec NL, Galin RS, Hughes TE, Buesching DP.

Clin Ther. 1994 Jul-Aug;16(4):715-30; discussion 74.

PMID:
7982260
20.

Treatment patterns and costs in patients with generalised anxiety disorder: one-year retrospective analysis of data from national registers in Sweden.

Sandelin R, Kowalski J, Ahnemark E, Allgulander C.

Eur Psychiatry. 2013 Feb;28(2):125-33. doi: 10.1016/j.eurpsy.2012.02.003. Epub 2012 Apr 26.

PMID:
22542328
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk